Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)
Rodney P. Rocconi(University of Mississippi Medical Center), Sharmila Makhija(University of Alabama at Birmingham), A. Rivera(University of Alabama at Birmingham), Meng Wang(Chinese Academy of Sciences), Mariam A. Stoff‐Khalili(University of Groningen), B LU(National Institute of Biological Sciences, Beijing), Ronald D. Alvarez(Vanderbilt University Medical Center), David T Curiel(University of Alabama at Birmingham), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention)
Cited by 34
Related Papers
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
|Science|2009|1.9k
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
|Journal of the National Comprehensive Cancer Network|2019|332
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298